Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Details Narrative)

v3.21.2
Stock-based Compensation (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Aug. 05, 2021
Jul. 02, 2021
Oct. 06, 2020
Aug. 05, 2020
Aug. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based compensation expense           $ 2,257,863 $ 357,039  
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price           $ 17.06   $ 17.06
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 10.66   $ 10.66
Class of Warrant or Right, Outstanding           303,725   303,725
Warrants and Rights Outstanding, Maturity Date           Feb. 16, 2023   Feb. 16, 2023
PIPE Transactions [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Class of Warrant or Right, Outstanding           153,725   153,725
Warrant [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of warrants vested           112,500    
Restricted Stock Units (RSUs) [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested           114,531    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number           369,461   369,461
Restricted Stock Units (RSUs) [Member] | 2019 Omnibus Incentive Plan [Member] | Service Condition [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period   79,572            
Restricted Stock Units (RSUs) [Member] | 2019 Omnibus Incentive Plan [Member] | Performance Condition [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period   119,358            
Terms of vesting   (i) 39,786 RSUs vest upon the completion of the interim analysis of Cohorts 1 and 2 for our PCS6422 Phase 1B clinical trial; (ii) 39,786 RSUs vest upon the completion of the interim analysis of our PCS499 Phase 2B clinical trial; and (iii) 39,786 RSUs vest upon the next capital raise(s) totaling a cumulative amount of at least $30 million            
Restricted Stock [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested           239,374    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period         324,360      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 55,142              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number           344,513   344,513
Restricted Stock [Member] | 2019 Omnibus Incentive Plan [Member] | Up-List to the Nasdaq [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares     214,078          
Consultants [Member] | Restricted Stock Units (RSUs) [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested           12,500    
Consultants [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Prepaid expenses           $ 107,193   $ 107,193
Consultants [Member] | Warrant [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested           112,500    
Number of warrants vested           100,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period           150,000    
Consultants [Member] | Restricted Stock Units (RSUs) [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested           13,800    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period           17,800    
Employees and Directors [Member] | Restricted Stock [Member] | 2019 Omnibus Incentive Plan [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period       324,360        
Number of shares forfeited               29,847
Employees and Directors [Member] | Restricted Stock [Member] | 2019 Omnibus Incentive Plan [Member] | Second Year Anniversary [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 53,610              
Employees [Member] | Restricted Stock Units (RSUs) [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested           100,731    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period           351,661    
Employees [Member] | Restricted Stock Units (RSUs) [Member] | 2019 Omnibus Incentive Plan [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period   198,930            
Employees [Member] | Restricted Stock Units (RSUs) [Member] | 2019 Omnibus Incentive Plan [Member] | Vest On July One Two Thousand And Twenty Two [Member] | Service Condition [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested   39,786            
Employees [Member] | Restricted Stock Units (RSUs) [Member] | 2019 Omnibus Incentive Plan [Member] | Vest on July 1, 2023 [Member] | Service Condition [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested   39,786            
Employees [Member] | Restricted Stock [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of restricted stock vested              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period           37,500